Structural and immunological characterization of human cytomegalovirus gp55-116 (gB) expressed in insect cells

References

1. Alford C. A., Stagno S., Pass R. 1980; Natural history of perinatal cytomegalovirus infection. In Perinatal Infections 77 pp. 125–247 New York: Elsevier/North-Holland;
   [Google Scholar]
2. Andreoni M., Faircloth M., Vugler L., Britt W. J. 1989; A rapid microneutralization assay for the measurement of neutralizing antibody reactive with human cytomegalovirus. Journal of Virological Methods 23:157–168
   [Google Scholar]
3. Betts R. F., Schmidt S. G. 1981; Cytolytic IgM antibody to cytomegalovirus in primary cytomegalovirus infection in humans. Journal of Infectious Diseases 143:821–826
   [Google Scholar]
4. Borysiewicz L.K, Graham S., Sinclair J., Cranage M. P., Smith G. L., Sissons J. G. P. 1988; Human cytomegalovirus-specific cytotoxic T cells. Relative frequency of stage-specific CTL recognizing the 72-kD immediate early protein and glycoprotein B expressed by recombinant vaccinia viruses. Journal of Experimental Medicine 168:919–931
   [Google Scholar]
5. Britt W. J. 1984; Neutralizing antibodies detect a disulfide-linked glycoprotein complex within the envelope of human cytomegalovirus. Virology 135:369–378
   [Google Scholar]
6. Britt W. J., Auger D. 1985; Identification of a 65,000 daltonvirion envelope of human cytomegalovirus. Virus Research 4:31–36
   [Google Scholar]
7. Britt W. J., Auger D. 1986; Synthesis and processing of the envelope gp55-116 complex of human cytomegalovirus. Journal of Virology 58:185–191
   [Google Scholar]
8. Britt W. J., Vugler L. G. 1989; Processing of the gp55-116 envelope glycoprotein complex (gB) of human cytomegalovirus. Journal of Virology 63:403–410
   [Google Scholar]
9. Britt W. J., Vugler L., Stephens E. B. 1988; Induction of complement-dependent and -independent neutralizing antibodies by recombinant-derived human cytomegalovirus gp55-116 (gB). Journal of Virology 62:3309–3318
   [Google Scholar]
10. Cranage M. P., Kouzarides T., Bankier A. T., Satchwell S., Weston K., Tomlinson P., Barrell B., Hart H., Bell S. E., Minson A. C., Smith G. L. 1986; Identification of the human cytomegalovirus glycoprotein B gene and induction of neutralizing antibodies via its expression in recombinant vaccinia virus. EMBO Journal 5:3057–3063
    [Google Scholar]
11. Drew W. L., Mintz L. 1984; Cytomegalovirus infection in healthy and immune-deficient homosexual men. In The Acquired Immune Deficiency Syndrome and Infections of Homosexual Men pp. 117–123 Ma P., Armstrong D. Edited by New York: Yorke Medical Books;
    [Google Scholar]
12. Estes M. K., Crawford S. E., Penaranda M. E., Petrie B., Burns J., Chan W., Ericson B., Smith G., Summers M. 1987; Synthesis and immunogenicity of the rotavirus major capsid antigen using a baculovirus expression system. Journal of Virology 61:1488–1494
    [Google Scholar]
13. Forman S. J., Zaia J. A., Clark B. R., Wright C. L., Mills B. J., Pottathil R., Racklin B. C., Gallagher M. T., Welte K., Blume K. G. 1985; A 64,000 dalton matrix protein of human cytomegalovirus induces in vitro immune responses similar to those of whole viral antigen. Journal of Immunology 134:3391–3395
    [Google Scholar]
14. Fraser M. J. 1989; The baculovirus infected insect cell as a eukaryotic gene expression system. In Viral Expression Vectors. Current Topics in Microbiology and Immunology New York: Springer-Verlag; in press
    [Google Scholar]
15. Gretch D. R., Kari B., Rasmussen L., Gehrz R., Stinski M. 1988; Identification and characterization of three distinct families of glycoprotein complexes present in the envelopes of human cytomegalovirus. Journal of Virology 62:875–881
    [Google Scholar]
16. Ho M. 1982; Cell-mediated immunity to cytomegalovirus infection. In Cytomegalovirus, Biology and Infection: Current Topics in Infectious Diseases pp. 105–118 Greenough W. B. III Merigan T. C. Edited by New York: Plenum Press;
    [Google Scholar]
17. Hsieh P., Robbins P. W. 1984; Regulation of asparagine-linked oligosaccharide processing. Journal of Biological Chemistry 259:2375–2382
    [Google Scholar]
18. Hu S. L., Kosowski S. G., Schaaf K. F. 1987; Expression of envelope glycoproteins of human immunodeficiency virus by an insect virus vector. Journal of Virology 61:3617–3620
    [Google Scholar]
19. Hurwitz D. 1988; Expression, glycosylation, and secretion of human EGF-receptor extracellular domain. International Conference on Baculovirus NERC Institute of Virology, Oxford University, Oxford, U.K:August30September3
    [Google Scholar]
20. Inumaru S., Roy P. 1987; Production and characterization of the neutralization antigen VP2 of bluetongue virus serotype 10 using a baculovirus expression vector. Virology 157:472–479
    [Google Scholar]
21. Kuroda K., Hauser C., Rott R., Klenk H. D., Doerfler W. 1987; Expression of the influenza virus hemagglutinin in insect cells by a baculovirus vector. EMBO Journal 5:1359–1365
    [Google Scholar]
22. Kuroda K., Hauser C., Rott R., Klenk H. D., Doerfler W. 1986; Biologically active influenza virus hemagglutinin expressed in insect cells by a baculovirus vector. In Biotechnology in Invertebrate Pathology and Cell Culture pp. 235–249 Maramorosch K. Edited by New York: Academic Press;
    [Google Scholar]
23. Lebacq-Verheyden A. M., Kasprzyk P. G., Raum M. G., Van Wyke Coelingh K., Lebacq J. A., Battey J. F. 1988; Posttranslational processing of endogenous and of baculovirus-expressed human gastrin-releasing peptide precursor. Molecular and Cellular Biology 8:3129–3135
    [Google Scholar]
24. Liu Y. N., Kari B., Gehrz R. C. 1988; Human immune responses to major human cytomegalovirus glycoprotein complexes. Journal of Virology 62:1066–1070
    [Google Scholar]
25. Matsuura Y., Possee R. D., Bishop D. H. L. 1986; Expression of the S-coded genes of lymphocytic choriomeningitisarenavirus using a baculovirus vector. Journal of General Virology 67:1515–1529
    [Google Scholar]
26. Matsuura Y., Possee R. D., Overton H. A., Bishop D. H. L. 1987; Baculovirus expression vectors: the requirements for high level expression of proteins, including glycoproteins. Journal of General Virology 68:1233–1250
    [Google Scholar]
27. Meyers J. D., Flournoy N., Thomas E. D. 1980; Cytomegalovirus infection and specific cell-mediated immunity after marrow transplant. Journal of Infectious Diseases 142:816–824
    [Google Scholar]
28. Murphy C. I., Weiner B., Bikel I., Piwnica-Worms H., Bradley M. K., Livingston D. M. 1988; Purification and functional properties of simian virus 40 large and small T antigens overproduced in insect cells. Journal of Virology 62:2951–2959
    [Google Scholar]
29. Nowak B., Sullivan C., Sirnow P., Thomas R., Bircont R., Nicolas J. C., Fleckenstein B., Levine A. J. 1984; Characterization of monoclonal antibodies and polyclonal immune sera directed against human cytomegalovirus virion proteins. Virology 132:325–338
    [Google Scholar]
30. Pereira L., Hoffman M., Tatsuno M., Dondero D. 1984; Polymorphism of human cytomegalovirus glycoproteins characterized by monoclonal antibodies. Virology 139:73–86
    [Google Scholar]
31. Possee R. D. 1986; Cell-surface expression of influenza virus hemagglutinin in insect cells using a baculovirus vector. Virus Research 5:43–59
    [Google Scholar]
32. Quinnan G. V. Jr Kirmani N., Rook A. H., Manischewitz J. F., Jackson L., Moreschi G., Santos G. W., Saral R., Burns W. B. 1982; HLA-restricted T-lymphocyte cytotoxic responses correlate with recovery from cytomegalovirus infection in bone- marrow-transplant recipients. New England Journal of Medicine 307:7–13
    [Google Scholar]
33. Rasmussen L. E., Nelson R. M., Kelsall D. C., Merigan T. C. 1984; Murine monoclonal antibody to a single protein neutralizes the infectivity of human cytomegalovirus. Proceedings of the National Academy of Sciences, U.S.A 81:876–880
    [Google Scholar]
34. Rusche J. R., Lynn D. L., Robert-Guroff M., Langlois A. J., Lyerly H. K., Carson H., Krohn K., Ranki A., Gallo R. C., Bolognesi D. P., Putney S. D., Matthews T. J. 1987; Humoral immune response to the entire human immunodeficiency virus envelope glycoprotein made in insect cells. Proceedings of the National Academy of Sciences, U.S.A 84:6924–6928
    [Google Scholar]
35. Spaete R. R., Thayer R. M., Probert W. S., Masiarz F. R., Chamberlain S. H., Rasmussen L., Merigan T. C., Pachl C. 1988; Human cytomegalovirus strain Towne glycoprotein B is processed by proteolytic cleavage. Virology 167:207–225
    [Google Scholar]
36. Stagno S., Pass R. F., Dworsky M. E., Alford C. A. 1983; The nature of maternal cytomegalovirus infection and its consequences for the infant. In Human Immunity to Viruses pp. 219–239 Ennis F. A. Edited by New York: Academic Press;
    [Google Scholar]
37. Stinski M. 1976; Human cytomegalovirus: glycoproteins associated with virions and dense bodies. Journal of Virology 19:594–609
    [Google Scholar]
38. Summers M. D., Smith G. E. 1987; A manual of methods for baculovirus vectors and insect cell culture procedures. Texas Agricultural Experiment Station Bulletin. 1555
    [Google Scholar]
39. Van Der Voort L. H. M., De Leij L. F. M. H., The T. H. 1989; Characterization of membrane antigens on human cytomegalovirus-infected fibroblasts recognized by human antibodies. Journal of Virology 63:1485–1488
    [Google Scholar]
40. Zhang Y. M., Hayes E. P., Mccarty T. C., Dubois D. K., Summers P. L., Eckels K. H., Chanock R. M., Lai C. J. 1988; Immunization of mice with dengue structural proteins and nonstructural protein NS1 expressed by a baculovirus recombinant induces resistance to dengue virus encephalitis. Journal of Virology 62:3027–3031
    [Google Scholar]